A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma

NCT07746687 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: JNJ-95597528
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC